Treace Medical Concepts (TMCI) Receivables (2020 - 2026)

Treace Medical Concepts' Receivables history runs 7 years deep, the most recent figure standing at $30.4 million for Q1 2026.

• Quarterly Receivables fell 2.42% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (down 2.42% YoY) and the FY2025 annual result came in at $42.2 million, up 3.31% from the prior year.
• Receivables was $30.4 million for Q1 2026 at Treace Medical Concepts, down from $42.2 million in the prior quarter.
• Across five years, Receivables topped out at $42.2 million in Q4 2025 and bottomed at $16.0 million in Q1 2022.
• A 5-year average of $28.4 million and a median of $29.2 million in 2022 frame the typical range for Receivables.
• Annual changes were most pronounced in 2023 — Receivables surged 65.03% — and 2024, when it slipped 6.14%.
• Treace Medical Concepts' Receivables stood at $29.2 million in 2022, then jumped by 30.5% to $38.1 million in 2023, then increased by 7.09% to $40.8 million in 2024, then increased by 3.31% to $42.2 million in 2025, then decreased by 27.98% to $30.4 million in 2026.
• Business Quant data shows TMCI's Receivables at $30.4 million in Q1 2026, $42.2 million in Q4 2025, and $33.0 million in Q3 2025.